KAUST's Industry Collaboration Program (KICP) held its 16th Industry Advisory Board meeting, adding the Ministry of Health, GADD, KFSRC, and NEOM as new members. Since 2009, KICP has enabled $250 million in research funding and provided $138 million in consultancy services, hiring 426 KAUST students. KICP also announced a new three-year agreement with KACARE to expand joint research in energy, sustainability, and advanced systems and research projects with GADD. Why it matters: The expansion of KICP underscores KAUST's role in aligning research with Saudi Arabia's Vision 2030 by fostering collaboration between academia, government, and industry.
The Saudi Ministry of Health and KAUST have signed an agreement to boost collaboration in healthcare innovation and investment. The partnership aims to develop a sustainable ecosystem supporting applied research and advanced technologies in healthcare, aligning with Saudi Vision 2030. The collaboration includes joint initiatives, workshops, training, and data exchange to enhance health innovation. Why it matters: This agreement signifies a strong push towards AI-based healthcare and precision medicine in Saudi Arabia, leveraging academic research for practical applications.
KAUST alumnus Grant Hill-Cawthorne, who earned a Ph.D. in pathogen genomics in 2013, is now the director of research at the UK Parliament. Hill-Cawthorne's work at KAUST involved establishing the Pathogen Genomics Laboratory with a focus on mass gatherings like Hajj and their influence on disease spread. He also worked with the Saudi Ministry of Health to study respiratory samples from Hajj pilgrims. Why it matters: This highlights KAUST's role in training researchers who go on to influence global health policy and research, particularly in areas relevant to Saudi Arabia's unique context.
This paper examines the relationship between COVID-19 spread and weather patterns across 89 cities in Saudi Arabia using machine learning. The study uses daily COVID-19 case reports from the Saudi Ministry of Health and historical weather data. The results indicate that temperature and wind speed have the strongest correlation with the spread of COVID-19, with a random forest model achieving the best performance.
KAUST and Lean Business Services (the digital arm of the Saudi health sector) have signed a Memorandum of Understanding to advance AI and data science for a "smart health" ecosystem in Saudi Arabia. During the COVID-19 pandemic, they collaborated to provide the Saudi Ministry of Health with AI-driven trends and analysis. KAUST's Shaheen II supercomputer was utilized to process healthcare data. Why it matters: This partnership aims to develop AI and advanced analytics solutions to enhance healthcare access, quality, and cost-efficiency in line with Saudi Vision 2030.
KAUST President announced a mandatory COVID-19 screening program for employees and students from November 1-5. The program aims to provide snapshots of COVID-19 prevalence in the community to inform healthcare demands and future plans. The university targets 5,000 individual swabs in partnership with the Ministry of Health, and participation is crucial for the program's success. Why it matters: This proactive measure enables KAUST to maintain a safe environment and continue reopening the campus, setting an example for managing the pandemic sustainably in the region.
The KAUST Pathogen Genomics Laboratory (PGL), led by Professor Arnab Pain, is using DNA and RNA sequencing to study the SARS-CoV-2 virus. The lab is part of KAUST's Rapid Research Response Team (R3T), supporting Saudi healthcare stakeholders in combating COVID-19. Pain and his Ph.D. student Sharif Hala are partnering with the Saudi-CDC and Ministry of Health hospitals to sequence Saudi SARS-CoV-2 samples. Why it matters: This effort provides crucial data for understanding and monitoring the virus's spread and evolution within the Kingdom, informing public health strategies.
KAUST reflects on its COVID-19 response, highlighting community efforts, research contributions, and partnerships. Faculty are leveraging expertise in diagnostics, AI therapeutics, genomics, and epidemiology. KAUST is collaborating with the Saudi CDC, Ministry of Health, and other institutions. Why it matters: This demonstrates KAUST's role as a hub for research and innovation, contributing to both national and global health challenges during a crisis.